ethamsylate has been researched along with deoxyguanosine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanai, T; Matsui, T; Matsumoto, S; Oka, M; Tanaka, M; Uemura, H | 1 |
| Fukui, T; Matsui, T; Nomiya, M; Oka, M; Oyama, T; Sagawa, K; Tanaka, M; Yamaguchi, O | 1 |
1 trial(s) available for ethamsylate and deoxyguanosine
| Article | Year |
|---|---|
Eviprostat suppresses urinary oxidative stress in a rabbit model of partial bladder outlet obstruction and in patients with benign prostatic hyperplasia.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antioxidants; Deoxyguanosine; Drug Combinations; Ethamsylate; Humans; Male; Middle Aged; Oxidative Stress; Phytotherapy; Plant Extracts; Prostatic Hyperplasia; Rabbits; Urinary Bladder Neck Obstruction | 2010 |
1 other study(ies) available for ethamsylate and deoxyguanosine
| Article | Year |
|---|---|
Suppression of bladder overactivity and oxidative stress by the phytotherapeutic agent, Eviprostat, in a rat model of atherosclerosis-induced chronic bladder ischemia.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Atherosclerosis; Deoxyguanosine; Drug Combinations; Ethamsylate; Interleukin-8; Ischemia; Male; Malondialdehyde; Models, Animal; Oxidative Stress; Plant Extracts; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Urinary Bladder; Urinary Bladder, Overactive; Urination; Urodynamics | 2012 |